Study the role of systemic endotoxemia as driver of chronic inflammation in arthritis
PI: Kari Eklund
Líder del WP3: Rodolfo Gómez Vaamonde
Funding agency: Unión Europea (Research Executive Agency-European Commission)
Funding (in thousands of euros): 7.000.000 €
Duration (funding period): (01/01/2023 – 31/12/2026)
Olive-Net: Bioactive compounds from Olea europaea: investigation and application in food, cosmetic and pharmaceutical industry
PI: Alexios Leandros Skaltsounis.
Funding agency: Unión Europea (Research Executive Agency-European Commission)
Funding (in thousands of euros): 1.732.500 €
Duration (funding period): 5 years (01/03/2017 – 31/08/2022)
Therapy for the Prevention of HO Recurrence (TPHOR) trial (Stage I)
PI: Rodolfo Gómez Bahamonde
Funding agency: conect4children – Collaborative network for European clinical trials for children (IMI initiative)
Funding (in thousands of euros): 2.500€
Duration (funding period): 0/1 year (01/10/2018 – 01/01/2019)
Identification of biomarkers and therapeutic targets in blood extracellular vesicles from patients with neurogenic heterotopic ossification
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 258.750 €
Duration (funding period): 3 years (01/01/2026 – 31/12/2028)
Identification of biomarkers and factors involved in articular heterotopic ossification and their relationship with innate immune responses
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 220.220 €
Duration (funding period): 3 years (01/01/2023 – 31/12/2025)
Circulating cellular characterization and pharmacological inhibition of abnormal bone growth associated with heterotopic ossification
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 208.120€
Duration (funding period): 3 years (01/01/2020 – 31/12/2022)
Integrated unit of biobank, 3D biomodels, and animal models at IDIS: a complete translational research pipeline.
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 232.650 €
Duration (funding period): 3 years. (01/01/2021 – 31/12/2023)
Study of transcription factors associated with changes in DNA methylation during osteoblastogenesis and their role in osteoblast differentiation
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 110.715€
Duration (funding period): 3 years (01/01/2017 – 31/12/2019)
Role of LCN2 in osteoarthritis-subchondral bone alterations and new pharmacological approaches to block its induction and other innate immune responses in joint tissues
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 121.500€
Duration (funding period): 3 yerars (01/01/2016 – 31/12/2018)
Development of a first-in-class therapy for the treatment of osteoarthritis based on microRNA-inhibiting oligonucleotides (CPP2021-008792).
PI: Arthex Biothech, S.L.
Funding agency: Ministerio de Ciencia e Innovacción
Funding (in thousands of euros): 987.445 €
Duration (funding period): 4 years (02/05/2022 – 02/05/2025)
Clinical-molecular study for the validation of personalized therapeutic strategies in pediatric-onset ectopic ossification syndromes.
PI: Rodolfo Gómez Bahamonde
Funding agency: Fundación Mutua Madrileña
Funding (in thousands of euros): 110.000 €
Duration (funding period): 3 years (01/10/2025 -30/09/2028)
Generation of functional surfaces for externalized endomedullar implants
PI: Alberto Jorge Mora
Funding agency: Fundación Mutua Madrileña
Funding (in thousands of euros): 135.000 €
Duration (funding period): 3 years (01/10/2020 -01/10/2023)
Search for soluble factors involved in heterotopic ossification associated with traumatic brain injury.
PI: Rodolfo Gómez Bahamonde
Funding agency: Fundación Mutua Madrileña
Funding (in thousands of euros): 120.000€
Duration (funding period): 3 years (01/07/2018 -01/07/2021)
Xunta de Galicia Growth Potential Groups (IN607B-2025/15)
PI: Rodolfo Gómez Vaamonde
Funding agency: Xunta de Galicia
Funding (in thousands of euros): 124.500 €.
Duration (funding period): 3 years (2025 – 2027)
Xunta de Galicia Growth Potential Groups (IN607B-2022-09)
PI: Rodolfo Gómez Vaamonde
Funding agency: Xunta de Galicia
Funding (in thousands of euros): 90.000 €.
Duration (funding period): 3 years (01/09/2022 – 31/12/2024)
3D models for training ultrasound-guided puncture techniques
PI: Ana Lois Iglesias
Funding agency: Colegio de Medicos de Coruña
Funding (in thousands of euros): 1.980 €
Duration: 1 year
3D-printed model for research and training in traumatology
PI: Alberto Jorge Mora
Funding agency: Colegio de Medicos de Coruña
Funding (in thousands of euros): 2.100 €
Duration: 1 year
New therapy for heterotopic ossification – A4VAL
PI: Rodolfo Gómez Bahamonde
Funding agency: Agencia pública gallega para la Gestion del Conocimiento (ACIS)
Funding (in thousands of euros): 20.000€
Duration (funding period): 1 year (02/09/2019 -15/12/2019)
New therapy for heterotopic ossification-I4TRANSF
PI: Rodolfo Gómez Bahamonde
Funding agency: Agencia pública gallega para la Gestion del Conocimiento (ACIS)
Funding (in thousands of euros): 5.000€
Duration (funding period): 0/1 year (02/09/2019 -15/12/2019)
STOP OSTEOARTHRITIS: blocking the origin of inflammation
PI: Rodolfo Gómez Bahamonde
Funding agency: Fundación Española para la Ciencia y la tecnología-(FECYT)/ Precipita
Funding (in thousands of euros): 5.730 €.
Duration (funding period): 1 year (30/10/2018 – 30/10/2019)
Computerized 3D-printed model for research and training in traumatology
Funding agency: AOTRAUMA España
Funding (in thousands of euros): 7500 francos suizos (7016,53€)
Duration (funding period): 1 year (2019)
Expediente contrato/proyecto: SPI 000371
Search for new drugs that inhibit inflammation associated with TLR4 in human osteoarthritic chondrocytes
PI: Ana Lois Iglesias
Funding agency: Fundación Española de Reumatología
Funding (in thousands of euros): 22000 €.
Duration (funding period): : 2 years (02/2019 – 02/2021)
Nanostructured surface modifications of titanium and sintering with calcium ions
PI: Rodolfo Gómez Bahamonde
Funding agency: Empresa privada Medcom Tech S.A.
Funding (in thousands of euros): 4.000€
Duration (funding period): : 0/1 year (08/03/2018 – 08/07/2018)